Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
- Conditions
- GIST
- Interventions
- Other: non-interventional
- Registration Number
- NCT01459757
- Lead Sponsor
- Pfizer
- Brief Summary
Retrospective correlation of clinical outcomes data with mutational status in GIST subjects treated with sunitinib.
- Detailed Description
This is a non-interventional trial. No active patients will participate in this study. Only data generated from the A6181036 study will be utilized for correlational purposes. The A6181036 study data in addition to mutational status data previously analyzed but not collected as part of the A6181036 study in the same patient population
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 322
- GIST subjects that participated in the A6181036 study that had mutational status data analyzed.
- Subjects not participating in the A6181036 study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Data generated from the past sunitinib A6181036 GIST study non-interventional -
- Primary Outcome Measures
Name Time Method Mutational status data retrospectively accessed correlated with A6181036 clinical outcomes data in GIST subjects treated with sunitinib 9 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (36)
Tata Memorial Centre
🇮🇳Mumbai, Maharashtra, India
Helsingin yliopistollinen keskussairaala/Syopatautien klinikka
🇫🇮Helsinki, Finland
Shands Hospital at the University of Florida
🇺🇸Gainesville, Florida, United States
Davis Cancer Pavilion and Shands Medical Plaza
🇺🇸Gainesville, Florida, United States
Ashford Cancer Centre Research
🇦🇺Kurralta Park, South Australia, Australia
Hopital Notre-dame du Centre Hospitalier Universitaire de Montreal
🇨🇦Montreal, Quebec, Canada
City of Hope
🇺🇸Duarte, California, United States
Washington Hospital Center
🇺🇸Washington, District of Columbia, United States
Schwerpunktpraxis fuer ambulante Tumortherapie
🇩🇪Duesseldorf, Germany
HELIOS Klinikum Berlin-Buch, Klinik fuer Interdisziplinaere Onkologie
🇩🇪Berlin, Germany
Institut Bergonie
🇫🇷Bordeaux Cedex, France
Seattle Cancer Care Alliance
🇺🇸Seattle, Washington, United States
CHU La Timone, Service d'Oncologie Medicale
🇫🇷Marseille, France
Oregon Health and Science University
🇺🇸Portland, Oregon, United States
Prince of Wales Hospital, Oncology Day Center
🇦🇺Randwick, New South Wales, Australia
UZ Leuven
🇧🇪Leuven, Belgium
Klinikum der Universitaet zu Koeln
🇩🇪Koeln, Germany
Moffitt Cancer Center
🇺🇸Tampa, Florida, United States
Dana-Farber Cancer Institute
🇺🇸Boston, Massachusetts, United States
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States
Centre L� B�rd
🇫🇷Lyon Cedex, France
Christie Hospital NHS Trust
🇬🇧Manchester, United Kingdom
Herlev Hospital
🇩🇰Herlev, Denmark
Sarcoma Unit
🇬🇧London, United Kingdom
Shands Cancer Hospital at the University of Florida
🇺🇸Gainesville, Florida, United States
Masonic Cancer Center - Clinical Trials Office
🇺🇸Minneapolis, Minnesota, United States
Seoul National University Hospital/Department of Internal Medicine
🇰🇷Seoul, Korea, Republic of
Leids Universitair Medisch Centrum/ Klinische Oncologie
🇳🇱Leiden, Netherlands
Asan Medical Center, Department of Internal Medicine
🇰🇷Seoul, Korea, Republic of
Klinika Nowotworow Tkanek Miekkich i Kosci
🇵🇱Warszawa, Poland
Narodny Onkologicky ustav
🇸🇰Bratislava, Slovakia
Hospital de la Santa Creu i Sant Pau
🇪🇸Barcelona, Spain
Hospital Universitario Virgen Macarena
🇪🇸Sevilla, Spain
Centre Hospitalier Universitaire Vaudois
🇨ðŸ‡Lausanne, Switzerland
University of Washington
🇺🇸Seattle, Washington, United States
Peter MacCallum Cancer Institute, Department of Medical Oncology
🇦🇺East Melbourne, Victoria, Australia